HomeAKBLF • OTCMKTS
add
ALK-Abello A/S
Nakaraang pagsara
$22.05
Sakop ng taon
$13.25 - $27.03
Market cap
32.15B DKK
Average na Volume
41.00
P/E ratio
-
Dividend yield
-
Primary exchange
CPH
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.31B | 18.29% |
Gastos sa pagpapatakbo | 536.00M | -0.37% |
Net na kita | 212.00M | 81.20% |
Net profit margin | 16.15 | 53.23% |
Kita sa bawat share | 1.00 | 100.00% |
EBITDA | 369.00M | 77.40% |
Aktuwal na % ng binabayarang buwis | 24.56% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 556.00M | 168.60% |
Kabuuang asset | 7.15B | 8.85% |
Kabuuang sagutin | 2.06B | -7.36% |
Kabuuang equity | 5.09B | — |
Natitirang share | 221.19M | — |
Presyo para makapag-book | 0.96 | — |
Return on assets | 10.78% | — |
Return on capital | 13.88% | — |
Cash Flow
Net change in cash
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 212.00M | 81.20% |
Cash mula sa mga operasyon | 218.00M | 22.47% |
Cash mula sa pag-invest | -65.00M | 17.72% |
Cash mula sa financing | -15.00M | 73.68% |
Net change in cash | 136.00M | 223.81% |
Malayang cash flow | 108.62M | 142.06% |
Tungkol
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
Itinatag
1923
Website
Mga Empleyado
2,795
